Eight Years On, Emcure Pharma Takes A Second Shot At IPO

[email protected]10 Nov, 2021News

Pune-based Emcure Pharmaceuticals Ltd is making its second attempt to float an initial public offering (IPO), joining a bunch of healthcare companies to tap into the stock market buoyancy. Emcure has filed a draft prospectus with the capital markets regulator Securities and Exchange Board of India for the IPO that includes both primary and secondary share sales. While the drugmaker aims to raise Rs 1,100 crore by issuing fresh shares in the IPO, its promoters and investor Bain Capital plan to sell a total of 18.16 million shares. Private equity firm Bain alone will sell almost 10 million shares.